Login / Signup

Decoration of Burkholderia Hcp1 protein to virus-like particles as a vaccine delivery platform.

Nittaya KhakhumNoe Baruch-TorresJacob L StocktonItziar Chapartegui-GonzálezAlexander J BadtenAwadalkareem AdamTian WangAlejandro Huerta-SaqueroY Whitney YinAlfredo G Torres
Published in: Infection and immunity (2024)
Virus-like particles (VLPs) are protein-based nanoparticles frequently used as carriers in conjugate vaccine platforms. VLPs have been used to display foreign antigens for vaccination and to deliver immunotherapy against diseases. Hemolysin-coregulated proteins 1 (Hcp1) is a protein component of the Burkholderia type 6 secretion system, which participates in intracellular invasion and dissemination. This protein has been reported as a protective antigen and is used in multiple vaccine candidates with various platforms against melioidosis, a severe infectious disease caused by the intracellular pathogen Burkholderia pseudomallei . In this study, we used P22 VLPs as a surface platform for decoration with Hcp1 using chemical conjugation. C57BL/6 mice were intranasally immunized with three doses of either PBS, VLPs, or conjugated Hcp1-VLPs. Immunization with Hcp1-VLPs formulation induced Hcp1-specific IgG, IgG 1 , IgG 2c , and IgA antibody responses. Furthermore, the serum from Hcp1-VLPs immunized mice enhanced the bacterial uptake and opsonophagocytosis by macrophages in the presence of complement. This study demonstrated an alternative strategy to develop a VLPs-based vaccine platform against Burkholderia species.
Keyphrases
  • protein protein
  • amino acid
  • high throughput
  • drug delivery
  • metabolic syndrome
  • dendritic cells
  • reactive oxygen species
  • photodynamic therapy
  • adipose tissue
  • insulin resistance